MESP2

MESP2 is a basic helix-loop-helix (bHLH) transcription factor that serves as a master regulator of vertebrate somitogenesis, translating the temporal segmentation clock into spatial rostro-caudal somite patterning. MESP2 is transcriptionally activated by Tbx6 binding to conserved T-box sites in its presomitic mesoderm (PSM) enhancer downstream of Notch signaling, and once expressed it directly binds E-box enhancers to activate targets including Epha4, Lfng, and Ripply2, while suppressing Notch signaling both transcriptionally (via Lfng induction) and post-translationally (by destabilizing the Notch co-activator MAML1 independently of its DNA-binding activity) (PMID:15902259, PMID:21098559, PMID:16728472, PMID:17360776). MESP2 further defines segmental borders by inducing ubiquitin-proteasome-dependent degradation of Tbx6, and its own expression is terminated by a Ripply2-mediated negative feedback loop, ensuring periodic and spatially restricted segment formation (PMID:18579680, PMID:17360776). Beyond somitogenesis, MESP2 regulates cardiac neural crest cell proliferation through cell-cycle factors and interacts with TCF7L2/β-catenin to modulate Wnt target gene expression (PMID:32572506, PMID:36854722).

1. 1997 High

   Establishing that MESP2 is essential for somite segmentation resolved the question of which transcription factor initiates rostro-caudal patterning in the presomitic mesoderm.

   Evidence Mesp2-null mice lack segmented somites and show disrupted Notch, Dll1, and FGF pathway gene expression

   PMID:9242490

   Open questions at the time

   • Mechanism by which MESP2 controls Notch/Dll1 expression was unknown
   • Direct transcriptional targets not identified
   • Whether MESP2 acts cell-autonomously was untested
2. 1998 High

   Demonstrating that MESP1 knock-in into the Mesp2 locus rescues segmentation established functional redundancy between the two paralogs and confirmed that MESP2's role in somitogenesis operates through shared downstream pathways.

   Evidence Mesp1 cDNA knock-in into Mesp2 locus restores Notch1/2 and FGFR1 expression and rescues skeletal defects dose-dependently

   PMID:9739106

   Open questions at the time

   • The basis for unique versus shared MESP1/MESP2 functions was unresolved
   • Direct DNA targets of either factor not yet identified
3. 2000 High

   Genetic epistasis with Presenilin-1 and Dll1 mutants revealed that MESP2 establishes rostral somite identity by activating a Presenilin-independent Notch pathway that suppresses Dll1, while Presenilin-mediated Notch signaling drives caudal identity — resolving how one transcription factor generates opposing compartment fates.

   Evidence Compound mutant analysis of Mesp2, Ps1, and Dll1; in situ hybridization for compartment markers

   PMID:10932180

   Open questions at the time

   • Identity of the Presenilin-independent Notch pathway component was unknown
   • Whether MESP2 directly acts on Dll1 enhancer or acts indirectly was unresolved
4. 2005 High

   Identification of Lunatic fringe (Lfng) as the Mesp2-induced suppressor of Notch activity provided the molecular mechanism by which MESP2 creates the segmental border at the interface of Notch-active and Notch-repressed domains.

   Evidence Knock-in Notch1 activity reporters, genetic epistasis, and biochemical assays in mouse embryos

   PMID:15902259

   Open questions at the time

   • Whether MESP2 directly binds the Lfng enhancer was not shown
   • Non-transcriptional mechanisms of Notch suppression by MESP2 were not yet discovered
5. 2006 High

   ChIP-based demonstration that Tbx6 directly binds the Mesp2 upstream enhancer, and that this binding mediates Notch-dependent Mesp2 activation, established the input logic gating MESP2 transcription in the anterior PSM.

   Evidence ChIP in cultured cells, reporter assays, analysis in Tbx6-null mice

   PMID:16505380 PMID:18849530

   Open questions at the time

   • How Notch signaling cooperates with Tbx6 at the enhancer at the chromatin level was unresolved
   • Periodicity mechanism linking the clock to Tbx6/Mesp2 activation was not fully explained
6. 2006 High

   Direct binding of MESP2 to the Epha4 E-box enhancer and gain-of-function induction of epithelialization genes identified the first confirmed direct transcriptional target and linked MESP2 to the cellular mechanics of border formation.

   Evidence ChIP/direct binding assay, transgenic reporter, luciferase assay, Mesp2 misexpression in somitic cells

   PMID:16728472

   Open questions at the time

   • Full repertoire of direct MESP2 transcriptional targets remained incomplete
   • How Epha4 activation translates to epithelialization was unexplored
7. 2007 High

   Discovery that MESP2 directly activates Ripply2, which then feeds back to terminate MESP2 expression, explained how MESP2 expression is temporally restricted to a single somite-forming unit.

   Evidence Microarray, ChIP/gel shift for direct Ripply2 enhancer binding, Ripply2 KO mouse with rostralized somite phenotype

   PMID:17360776

   Open questions at the time

   • Mechanism by which Ripply2 represses Mesp2 (direct or indirect, transcriptional or post-translational) was unclear
   • Whether Ripply2 feeds back on Tbx6 independently of MESP2 was unknown
8. 2008 High

   Demonstrating that MESP2 induces ubiquitin-proteasome-mediated degradation of Tbx6 protein provided the key mechanism by which MESP2 sharpens its own expression boundary and converts temporal clock periodicity into a spatial segment.

   Evidence High-resolution FISH, immunohistochemistry, proteasome inhibitor treatment in mouse embryos

   PMID:18579680

   Open questions at the time

   • The E3 ubiquitin ligase responsible for Tbx6 degradation was not identified
   • Whether MESP2 directly participates in the Tbx6 degradation complex or acts indirectly was unresolved
9. 2010 High

   Revealing that MESP2 destabilizes MAML1 to suppress Notch signaling independently of its DNA-binding/transcription factor function uncovered a dual-mode mechanism — transcriptional (via Lfng) and post-translational (via MAML1) — for Notch suppression by a single bHLH factor.

   Evidence Dominant-negative Rbpj knock-in into Mesp2 locus rescuing segmental defects; Co-IP and protein stability assays for MAML1

   PMID:21098559

   Open questions at the time

   • The domain of MESP2 responsible for MAML1 destabilization was not mapped
   • Whether MESP2 directly binds MAML1 or requires an adaptor was not resolved
10. 2015 High

    Ripply2 knock-in into the Mesp2 locus demonstrated that Ripply2 can independently suppress Tbx6 protein post-translationally, refining the segmental border model by showing that MESP2 is not the sole regulator of Tbx6 degradation.

    Evidence Ripply2 knock-in into Mesp2 locus, ectopic Ripply2 expression in PSM, protein versus mRNA analysis

    PMID:25641698

    Open questions at the time

    • The relative contributions of MESP2 versus Ripply2 to Tbx6 degradation in normal development were not quantified
11. 2020 Medium

    Functional analysis of MESP2 in cardiac neural crest cells expanded its known roles beyond somitogenesis, showing it regulates proliferation via p21/Cdk4 and activates cardiac transcription factors, with patient variants linked to conotruncal heart defects.

    Evidence Luciferase reporter assays, primary mouse CNCC cultures, cell cycle analysis, patient variant functional tests in HEK293T/JoMa1 cells

    PMID:32572506

    Open questions at the time

    • In vivo cardiac phenotype of MESP2 loss-of-function specifically in neural crest was not demonstrated
    • Whether these cardiac functions are bHLH DNA-binding dependent or involve the MAML1 destabilization mode was untested
12. 2022 Medium

    Chromatin conformation studies revealed that the Mesp2 enhancer can loop to activate the Mesp1 promoter upon Mesp2 loss, explaining the compensatory upregulation of Mesp1 and the locus-level regulatory logic of the Mesp1/Mesp2 genomic region.

    Evidence Cultured PSM induction system, chromatin conformation capture, transgenic reporters

    PMID:35025872

    Open questions at the time

    • Whether this enhancer-sharing occurs in vivo during normal embryogenesis was not confirmed
    • Factors mediating the loop formation were not identified
13. 2023 Medium

    Discovery that MESP2 binds TCF7L2 and inhibits the TCF4/β-catenin complex to suppress SKP2, thereby stabilizing p27 to restrain gastric cancer cell proliferation, revealed a Wnt-pathway-antagonistic function outside developmental contexts.

    Evidence Co-immunoprecipitation, ChIP, luciferase assays, in vitro and xenograft overexpression/knockdown in gastric cancer cells

    PMID:36854722

    Open questions at the time

    • Whether this TCF7L2 interaction is relevant in normal developmental tissues was not tested
    • Structural basis of MESP2–TCF7L2 interaction is unknown
    • Independent replication in additional cancer types is lacking

• The E3 ubiquitin ligase(s) responsible for MESP2-induced Tbx6 degradation remain unidentified, the structural basis for MESP2's non-transcriptional destabilization of MAML1 is unknown, and the full spectrum of direct genomic targets of MESP2 across its developmental and non-developmental roles has not been determined by genome-wide approaches.
• E3 ligase for Tbx6 degradation not identified
• No genome-wide binding profile (ChIP-seq) for MESP2
• MESP2 protein structure not solved
• Relative importance of transcriptional vs post-translational Notch suppression modes in vivo not quantified